|
Antonova A.A., Yamanova G.A., Murzova O.A., Abdurakhimova P.M.
Alagille syndrome: current understanding of pathogenesis, diagnostic and treatment issues (literature review)
|
№7 / 2025
|
|
Macharadze D.Sh.
New treatment options for severe atopic dermatitis: upadacitinib. Review
|
№7 / 2025
|
|
Orlova E.A., Kulieva O.A., Kandrashkina Yu.A., Levashova O.A., Nikolashina O.E., Rybalkin S.B.
The role of skin microbiota in the development of atopic dermatitis in pregnant women and their newborns: prospects for diagnosis and therapy
|
№7 / 2025
|
|
Pshenichnikova I.I., Zakharova I.N., Borzakova S.N., Belozerova A.D., Osmanov I.M.
Smoker’s cough in adolescents: pathogenesis, clinical features and use of butamirate
|
№7 / 2025
|
|
Mashanskaya A.V., Vlasenko A.V., Belogorova T.A., Berdina O.N., Bugun O.V., Rychkova L.V.
Home-based rehabilitation programs for children with cerebral palsy: validity, feasibility, and effectiveness (literature review)
|
№7 / 2025
|
|
Karpova E.P., Belov V.A., Asmanov A.I., Tulupov D.A., Naumov O.G.
Current approaches to the treatment of acute rhinosinusitis in children in outpatient practice
|
№7 / 2025
|
|
Krasilnikova S.V., Gorbunova K.V., Eliseeva T.I., Bulgakova V.A.
Endotypic heterogeneity of chronic rhinosinusitis
|
№7 / 2025
|
|
Pshenichnikova I.I., Zakharova I.N., Borzakova S.N., Pupykina V.V., Osmanov I.M.
Ezetimibe in the treatment of dyslipidemia in children and adolescents with types 1 and 2 diabetes mellitus: efficacy and safety
|
№7 / 2025
|
|
Vorobyeva I.N., Gmoshinskaya M.V., Aleshina I.V.
An interdisciplinary approach to breastfeeding support
|
№7 / 2025
|
|
Gmoshinskaya M.V., Pyryeva E.A.
Breastfeeding: yesterday and today
|
№7 / 2025
|
|
Svechnikova E.V., Zhufina S.E., Rzhevskaya E.V., Gladko V.V., Izmailova I.V.
Psoriasis of special localizations. Experience with the use of the interleukin-17A inhibitor netakimab for the treatment of psoriasis of special localizations
|
№5 / 2025
|
|
Sokolova A.V., Ilina T.D., Chebotareva Yu.Yu.
Clinical case: comparative results of using high-intensity focused electromagnetic stimulation with monopolar radio-wave lifting as monotherapy and in a combined protocol with botulinum toxin
|
№5 / 2025
|